CHARLESTON, W.Va. – Yesterday, U.S. Senators Shelley Moore Capito (R-W.Va.) and Joe Manchin (D-W.Va.), along with Senators Mark Warner (D-Va.), Tim Kaine (D-Va.), Marsha Blackburn (R-Tenn.), and Bill Hagerty (R-Tenn.), sent a letter to Dr. Rahul Gupta, Director of the Office of National Drug Control Policy (ONDCP), pressing for additional assistance to combat drug-trafficking in the Appalachian region.

While some counties in West Virginia have seen a slight decline in overdose deaths, West Virginia remains the state with the highest number of overdose in the country. According to the Centers for Disease Control and Prevention (CDC), in 2020, 1330 lives were lost to drug overdose – a death rate of 81.4 per 100,000 total population. The national average is 28.3 per 100,000.

“In Appalachia, law enforcement struggles to stem the tide of substance abuse,” the senators wrote in their letter to ONDCP. “In the words of then-Attorney General, William Barr, Appalachia has suffered the consequences of the opioid epidemic ‘more, perhaps, than any other region.’ In 2018, the overdose mortality rate for individuals ages 25-43 was 43 percent higher in Appalachia than the rest of the country. It is a region that needs the assistance that the HIDTA program was designed to provide.”

Since its creation in 1988, the High Intensity Drug Trafficking Areas (HIDTA) grant assistance program has provided for greater coordination and information sharing among federal, state, tribal, and local law enforcement agencies. These additional federal resources, allocated to areas deemed as critical drug trafficking regions, are essential in eliminating drug trafficking and its harmful consequences. ONDCP has the statutory authority to create new HIDTAs and add new counties to existing HIDTAs once it has received a formal petition from a coalition of law enforcement agencies.

Despite the enormous need, historically the Appalachian HIDTA has only gained approval for approximately 30% of petitions submitted. In the most recent round of designations, no counties within the Appalachian HIDTA – which encompasses West Virginia, Tennessee, Kentucky, and Southwest Virginia – received the sought-after designation.

“This fact, juxtaposed with the region’s manifest need, suggests strongly that the process of awarding needs to be revisited,” the senators continued. “Counties in the Appalachian HIDTA would benefit from the expansion of this program into their communities and it would be of immense help to the law enforcement agencies serving them and surrounding areas. As ONDCP reviews HIDTA designation petitions from Appalachia, we ask that you consider the devastating impacts of illegal drugs in the region in order to effectively disrupt and dismantle trafficking organizations and reduce drug-related crime.”

Concluded the senators, “We urge ONDCP to review its criteria to ensure that hard-hit regions like Appalachia remain competitive for HIDTA designations. We further request a written response describing the results of this review be provided in a timely manner.”

A copy of the letter is available below:

Dear Dr. Gupta:

We write today regarding the Office of National Drug Control Policy’s (ONDCP) High Intensity Drug Trafficking Areas (HIDTA) program and certain deficiencies in the designation process for counties in the Appalachian region.

Since its creation in 1988, the HIDTA grant assistance program has provided for greater coordination and information sharing among federal, state, tribal, and local law enforcement agencies. These additional federal resources, allocated to areas deemed as critical drug trafficking regions, are essential in eliminating drug trafficking and its harmful consequences.

As you know, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) provides ONDCP the statutory authority to create new HIDTAs and add new counties to existing HIDTAs once it has received a formal petition from a coalition of law enforcement agencies. HIDTA designation is determined by four criteria, which include an evidence based description detailing the extent of illegal drug activity, the impact on the area and the United States, existing efforts to curtail it, and the increased need for federal resources to respond adequately to the area’s drug-related activities.

In Appalachia, law enforcement struggles to stem the tide of substance abuse. In the words of then-Attorney General William Barr, Appalachia has suffered the consequences of the opioid epidemic “more, perhaps, than any other region.” In 2018, the overdose mortality rate for individuals ages 25-43 was 43% higher in Appalachia than the rest of the country.  It is a region that needs the assistance that the HIDTA program was designed to provide.

Yet, historically, the Appalachian HIDTA has only gained approval for approximately 30% of petitions submitted. And in this most recent round of designations, no counties within the Appalachian HIDTA received the sought after designation. This fact, juxtaposed with the region’s manifest need, suggests strongly that the process of awarding the designation needs to be revisited.

Counties in the Appalachian HIDTA would benefit from the expansion of this program into their communities and it would be of immense help to the law enforcement agencies serving them and surrounding areas. As ONDCP reviews HIDTA designation petitions from Appalachia, we ask that you consider the devastating impacts of illegal drugs in the region in order to effectively disrupt and dismantle trafficking organizations and reduce drug-related crime.

We urge ONDCP to review its criteria to ensure that hard hit regions like Appalachia remain competitive for HIDTA designations. We further request that a written response describing the results of this review be provided in a timely manner. 

# # #